There is a commercial access agreement for olaparib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening – results that give zero guidance to patients on whether they are at elevated risk.

The 1-year PFS rate was 75.2%, with a median PFS of 21.0 months, aligning with previous trials and highlighting olaparib's efficacy in maintaining remission in patients with HRD-positive ...

Muriz Memić, the father of the murdered young man Dženan Memić, stated today, on the ninth anniversary of the attack on his son Dženan in the Sarajevo neighborhood of Ilidža, that the state has ...